Literature DB >> 8057133

A long surviving case of recurrent medulloblastoma displaying effectiveness of ACNU/vincristine chemotherapy.

M Miyagami1, K Satoh, T Tsubokawa.   

Abstract

A favorable case of recurrent medulloblastoma, in which 19 years has elapsed with combination therapy due to surgery, radiation and chemotherapy since the initial operation, is reported. The case was a male of age 12 who was admitted due to medulloblastoma of the classical type. Tumor recurrences were observed 3 times within 7 years after the initial operation and radiation treatment. At the 3rd recurrence, a large tumor was found in the cerebellar vermis and left cerebellar hemisphere on CT with CSF dissemination and a high NSE level in the CSF (62 ng/ml). Only chemotherapy by intravenous administration of 2 courses of 120-150 mg ACNU (1.7-2.2 mg/kg) and 4 mg vincristine (0.06 mg/kg) with intrathecal administration of methotrexate was given at this time. The tumor image and gait disturbance with radicular pain disappeared completely and the NSE level in the CSF improved to within the normal range (5.4 ng/ml). The patient continues in complete remission, with a Karnovsky performance status of 100% at 4 years after the 3rd recurrence. We report full details of this case in which active treatments consisting mainly of chemotherapy proved to be effective for recurrent medulloblastoma, even though its prognosis is generally very unfavorable.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8057133     DOI: 10.1007/bf01324602

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  29 in total

1.  Recurrent medulloblastoma in children.

Authors:  S Nishio; M Fukui; I Takeshita; H Nakagaki; K Kitamura; K Jingu
Journal:  Neurol Med Chir (Tokyo)       Date:  1986-01       Impact factor: 1.742

2.  Medulloblastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival.

Authors:  E M Chatty; K M Earle
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

3.  Radiation treatment for medulloblastoma. A 21-year review.

Authors:  M P Berry; R D Jenkin; C W Keen; B D Nair; W J Simpson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

4.  Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study.

Authors:  C L Sexauer; A Khan; P C Burger; J P Krischer; J van Eys; T Vats; A H Ragab
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

5.  Period of risk for recurrence in medulloblastoma.

Authors:  D O Quest; R Brisman; J L Antunes; E M Housepian
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

6.  Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine.

Authors:  D C Crafts; V A Levin; M S Edwards; T L Pischer; C B Wilson
Journal:  J Neurosurg       Date:  1978-10       Impact factor: 5.115

7.  Treatment of medulloblastoma in children: long-term results following surgery, radiotherapy and chemotherapy.

Authors:  C Mazza; A Pasqualin; R Da Pian; E Donati
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

8.  Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomas. A preliminary report.

Authors:  J L Venes; S McIntosh; R T O'Brien; A D Schwartz
Journal:  J Neurosurg       Date:  1979-06       Impact factor: 5.115

9.  High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.

Authors:  J C Allen; L Helson
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

10.  Cisplatin therapy in recurrent childhood brain tumors.

Authors:  A B Khan; B J D'Souza; M D Wharam; L A Champion; L F Sinks; S Y Woo; D C McCullough; B G Leventhal
Journal:  Cancer Treat Rep       Date:  1982-12
View more
  3 in total

Review 1.  Importance of patient evaluation for long-term survival in medulloblastoma recurrence.

Authors:  F La Marca; T Tomita
Journal:  Childs Nerv Syst       Date:  1997-01       Impact factor: 1.475

2.  Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.

Authors:  E Leo; P G Schlegel; A Lindemann
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

3.  Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse?

Authors:  E Bouffet; F Doz; M C Demaille; P Tron; H Roche; D Plantaz; A Thyss; J L Stephan; O Lejars; E Sariban; M Buclon; J M Zücker; M Brunat-Mentigny; J L Bernard; J C Gentet
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.